Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,73 USD | +5,65% |
|
+28,19% | -51,72% |
Attività
Numero di dipendenti: 255
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 2 | 100,0 % | 12 | 100,0 % | +505,77% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 2 | 100,0 % | 12 | 100,0 % | +505,77% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Sekar Kathiresan
FOU | Founder | 52 | 01/01/18 |
Allison Dorval
DFI | Director of Finance/CFO | 48 | 29/11/21 |
Andrew Ashe
PSD | President | 57 | 01/08/18 |
Andrew Sheely
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jason Politi
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/21 |
Richard Falzone
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/04/21 |
Troy Lister
CTO | Chief Tech/Sci/R&D Officer | - | 01/05/22 |
Fred Fiedorek
CTO | Chief Tech/Sci/R&D Officer | 69 | 18/09/23 |
Joan Nickerson
ADM | Chief Administrative Officer | 56 | 01/04/21 |
Investor Relations Contact | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Burt Adelman
FOU | Founder | 71 | 01/01/18 |
Lonnel Coats
BRD | Director/Board Member | 58 | 08/08/22 |
Michael MacLean
BRD | Director/Board Member | 58 | 01/05/21 |
Sheila Mikhail
BRD | Director/Board Member | 57 | 01/04/21 |
Krishna Yeshwant
BRD | Director/Board Member | 45 | 01/08/18 |
Alexander Cumbo
BRD | Director/Board Member | 53 | 09/06/22 |
Sekar Kathiresan
FOU | Founder | 52 | 01/01/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 83 965 493 | 77 459 181 ( 92,25 %) | 0 | 92,25 % |
Coordinate società
![Indirizzo Verve Therapeutics, Inc.(VERV)](https://cdn.zonebourse.com/static/address/123776319.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-54,30% | 535 Mln | |
+23,50% | 47,07 Mrd | |
+47,41% | 42,06 Mrd | |
-5,16% | 39,98 Mrd | |
+36,37% | 33,02 Mrd | |
-7,79% | 27,9 Mrd | |
+18,06% | 27,63 Mrd | |
+47,29% | 14,37 Mrd | |
+41,91% | 13,45 Mrd | |
-1,02% | 12,03 Mrd |
- Borsa valori
- Azioni
- Azione VERV
- Società Verve Therapeutics, Inc.